Clinical Trials
9 trialsNCT05157594 2025-09-22
PROGLIO
Centre Jean Perrin
Completed
NCT05912400 2025-05-08
Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1
University of Arkansas
Completed
NCT02864563 2023-12-01
PHRCNB07
Institut Curie
Phase NA Completed
NCT02022384 2023-02-16
Immunophenotyping From Blood of Patients With Malignant Gliomas
University of Erlangen-Nürnberg Medical School
Completed
NCT01674582 2020-09-03
Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters
Lund University Hospital
Phase NA Completed
NCT02410577 2019-03-19
89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT02041611 2018-06-27
Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT01071837 2015-06-16
APG101 in Glioblastoma
Apogenix AG
Phase 2 Completed
NCT00897611 2012-11-30
Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed